πŸ‡ΊπŸ‡Έ FDA
Patent

US 6211154

Ketoheterocyclic inhibitors of factor Xa

expired A61KA61K38/00

Quick answer

US patent 6211154 (Ketoheterocyclic inhibitors of factor Xa) held by COR Therapeutics, Inc. expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
COR Therapeutics, Inc.
Grant date
Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K38/00